Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

3 years ago 356

Moderna banal was climbing successful premarket trading Friday aft an expert astatine Piper Sandler upgraded the shares and said the existent terms level was an charismatic introduction point.

Edward Tenthoff upgraded Moderna (ticker: MRNA) banal to Overweight from Neutral but near the people terms unchanged astatine $445, implying a adjacent 31% upside to the shares. Piper Sandler had downgraded the shares to neutral connected Aug. 6.

“Shares...

Read Entire Article

Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

Related

How To Unlock New Collaborations through Guest Blog Contribu...

Stock market news live updates: Stock futures rise after Nas...

Ford to book $8.2 billion fourth-quarter profit on Rivian in...

Good News for Retirees: RMD Formula Changing for First Time ...

Trending

Popular

Try on LeBron's jersey with 3D shopping experience built by ...

Insulin Isn't the Only Blood Sugar Regulator

Is Sony expanding PS5 backward compatibility?

Bob Saget's wife Kelly Rizzo shares an emotional tribute to ...

'I'm just so embarrassed': Bono really isn't U2's biggest fa...